| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| North America (Primary) | PRIMARYNOAM | Univ | 7,870 | 87,593,827 | -0.58% | 1.81% | 2.39% | 15.50% | 9.40% | 21.80% |
| Healthcare | HEALTHCARE | Sector | 1,205 | 7,047,879 | -0.15% | -0.81% | 5.11% | 6.25% | -1.18% | 17.02% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 598 | 3,914,578 | -0.28% | -0.52% | 5.82% | 8.09% | 5.37% | 39.62% |
| Other Biopharmaceuticals | BIOPHARMAOTHER | Industry | 114 | 1,494,133 | -0.11% | -0.35% | 4.30% | 2.54% | 6.36% | 35.15% |
| Toxicology Biopharmaceuticals | TOXICOLOGY | SubInd | 9 | 6,191 | -0.84% | -0.02% | 5.05% | 28.69% | -11.65% | 50.13% |
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,082 | 110,009,668 | -0.60% | 1.80% | 1.51% | 13.75% | 10.85% | 25.93% |
| Aquestive Therapeutics, Inc. | AQST:USAAQST:USA | Stock | 1 | 515 | 0.95% | 6.77% | 2.16% | 5.97% | -27.92% | 20.34% |
| Indivior Pharmaceuticals, Inc. | INDV:USAINDV:USA | Stock | 1 | 4,746 | -1.02% | -0.65% | 3.40% | 24.50% | 7.92% | 168.05% |
| Achieve Life Sciences, Inc. | ACHV:USAACHV:USA | Stock | 1 | 570 | -0.89% | -0.89% | 4.91% | 37.38% | 23.61% | 79.03% |
| Toxicology Biopharmaceuticals | TOXICOLOGY | SubInd | 9 | 6,191 | -0.84% | -0.02% | 5.05% | 28.69% | -11.65% | 50.13% |
* Colors indicate performance relative to the benchmark.